stella
beta
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors — Stella
Recruiting
Back to Solid Tumor trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(3 sites)
China
RenJi Hospital, Shanghai, Shanghai Municipality
Shanghai General Hospital, Shanghai, Shanghai Municipality
Fudan University Shanghai Cancer Center, Shanghai
View full record on ClinicalTrials.gov